Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis.

Condition(s) targeted: Psoriasis

Intervention: ENBREL (Biological); Enbrel (Drug); ENBREL (Biological)

Phase: Phase 4

Status: Recruiting

Sponsored by: Amgen

Official(s) and/or principal investigator(s):
MD, Study Director, Affiliation: Amgen

Overall contact:
Amgen Call Center, Phone: 866-572-6436

The purpose of this study is to evaluate the use of Enbrel® (etanercept) in the treatment of psoriasis in patients for a period of up to 1 year.

Official title: Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis

Study design: Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study

Primary outcome: PHYSICIAN GLOBAL ASSESSMENT

Secondary outcome: QOL, Safety

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: - 18 years of age or older Moderate to severe plaque psoriasis Able to

start Enbrel therapy per the approved product monograph Exclusion Criteria Active infections Evidence of skin conditions other than psoriasis that would interfere with study evaluations Subjects receiving Remicade (infliximab), Humira (adalimumab) or Amevive (alefacept)

Amgen Call Center, Phone: 866-572-6436

Research Site, Quebec, Canada; Recruiting

Research Site, Edmonton, Alberta, Canada; Completed

Research Site, Calgary, Alberta, Canada; Recruiting

Research Site, Vancouver, British Columbia, Canada; Recruiting

Research Site, Nanaimo, British Columbia, Canada; Recruiting

Research Site, Winnipeg, Manitoba, Canada; Recruiting

Research Site, SaintJohn, New Brunswick, Canada; Recruiting

Research Site, Moncton, New Brunswick, Canada; Recruiting

Research Site, St. John's, Newfoundland and Labrador, Canada; Recruiting

Research Site, Halifax, Nova Scotia, Canada; Recruiting

Research Site, Nepean, Ontario, Canada; Completed

Research Site, Markham, Ontario, Canada; Recruiting

Research Site, London, Ontario, Canada; Recruiting

Research Site, Milton, Ontario, Canada; Recruiting

Research Site, Toronto, Ontario, Canada; Recruiting

Research Site, Windsor, Ontario, Canada; Recruiting

Research Site, Oakville, Ontario, Canada; Recruiting

Research Site, Richmond Hill, Ontario, Canada; Recruiting

Research Site, Ottawa, Ontario, Canada; Recruiting

Research Site, NorthYork, Ontario, Canada; Recruiting

Research Site, Barrie, Ontario, Canada; Recruiting

Research Site, Burlington, Ontario, Canada; Completed

Research Site, Mississauga, Ontario, Canada; Recruiting

Research Site, Hamilton, Ontario, Canada; Recruiting

Research Site, Sarnia, Ontario, Canada; Recruiting

Research Site, Newmarket, Ontario, Canada; Recruiting

Research Site, Laval, Quebec, Canada; Completed

Research Site, Sherbrooke, Quebec, Canada; Recruiting

Research Site, Montreal, Quebec, Canada; Recruiting

Research Site, Ste-Anne, Quebec, Canada; Recruiting

AmgenTrials clinical trials website

Starting date: March 2006
Ending date: August 2009
Last updated: July 24, 2008